Chapter 666: [People are not in rivers and lakes and their influence is increasing day by day]

　　 "Mr. Lu, not only Bo Sheng Technology is supported by Luo Sheng, but also another high-profile medical equipment provider, Huachang Technology, also has Luo Sheng's capital background."
　　 "What did you say? Fuck it!"
　　The manager of the VC whose name was Lu heard this from the secretary, and for a moment he couldn't help but swear.
　　 This news is both good news and bad news for other venture capital institutions. The good news is that Luo Sheng is optimistic about its bright future. The bad news is that it is difficult to go directly to take a slice of the pie.
　　 With the great popularity in the medical expo, the attention of these two newly established technology companies has rapidly increased, especially Bo Chuang Technology, and the information of Chen Xinhe has also been further exposed quickly.
　　 doesn't need to be too much trouble. You can find some key information by opening the "Tianyancha" app on your mobile phone. You haven't caused such a big deal before because you didn't pay enough attention, and you didn't make any big news.
　　 One of the messages undoubtedly attracted much attention, that is, Luo Sheng’s name is awesome, and he is an angel investor of these two technology companies, and he invested in his own name.
　　 The outsiders have a strange feeling of inexplicable feeling. No wonder this is so beautiful. It turned out that there was Luo Sheng's support.
　　 In today's technology world, the name "Luo Sheng" has unparalleled magic. As long as the startup company or entrepreneur favored by the name or the organization behind the name can quickly become the darling of capital pursuit.
　　……
　　 "I'm sorry, Huachang Technology currently has no financing plan, and there is an agreement with Mr. Luo that only accepts Luo's exclusive investment unless he voluntarily gives up financing or he agrees to a third-party venture capital institution to come in."
　　 "Sorry Manager Lu, Bo Chuang Technology currently has no plans for external financing..."
　　After about half an hour, all the major VCs who came to the wind ran behind the booth and met Chen Xin and Chao Junhui respectively, with the purpose and directness, wanting to invest in their company.
But they were rejected without exception, which made the people of the major venture capital institutions very uncomfortable. If they are ordinary entrepreneurs and startup companies, this is shameless, and some are methods and means to succumb to the pressure of capital under.
　　 But these two can't do it. There is the name Luo Sheng for the bottom of it. No one dares to do that. In terms of capital strength, there is no venture capital institution in the world that can match Luo Sheng in terms of capital strength.
　　 Such a result made many VC organizations feel like crying without tears. Suddenly they were overjoyed by the discovery of the baby, seemingly at their fingertips, and found that it had nothing to do with themselves.
　　 Don't worry about it.
　　Why do these promising startups have the shadow of Luo Sheng? This makes many VC organizations feel extremely uncomfortable, but also have to admire, as the legend of the first person in contemporary science and technology is indeed well-known.
　　 After refusing to come to the door to talk to the VC person...
Afterwards, Chen Xin’s assistant walked over with an ieP tablet and handed it to him.
　　 "Mr. Chen, Mr. Luo sent you two emails."
　　Chen Xin took the tablet, clicked on the list of unread emails, and handed it back to his assistant in a moment. Without thinking, he directly commanded: "Just follow the steps above, get it as soon as possible, the sooner the better."
　　 "Mr. Chen, but Mr. Luo did not send us a payment. This batch of equipment is very expensive, and some have to go to Europe to purchase."
After hearing that, Chen Xin wanted to reprimand his assistant, but he refrained and said, "Then use the company's book current funds to do it first. Are you still worried that the old conference will not pay me this money? People who want to work for the boss There is no one thousand and no less than eight hundred. He gave me this matter to trust and value me. Know what to do?"
　　Don’t look at Chen Xin as a careless young post-90s, but he is also a master who knows things very well. He is clever and has a high double quotient.
　　 And his assistant was not the head of Elm. When he heard this, he immediately realized it and nodded: "Understood, I will deal with it immediately."
　　 Chen Xin's words, his assistant also quickly heard the pun intended, and now the matter is left to him to do, which is also trust and respect for himself.
　　If you don’t even realize this, then don’t try to climb up in the future.
　　 On the other side, Cao Junhui also received the news, and did not neglect this matter. He immediately arranged this matter. The father of the gold master had to wait for it. He could not be neglected, but it was a matter of running a leg.
　　 Moreover, this is not an ordinary errand, there are invisible benefits in it, which shows that the relationship with Luo Sheng is different from other founders.
　　 The relationship is very marvelous. Everyone in Shanghai is an elite and can judge a lot of valuable information from some seemingly inadvertent little things.
　　 In this realistic society, many things are done by people.
As Huachang Technology and Bochuang Technology became famous on the first day of the Medical Fair, they quickly spread in the industry. In addition to the product itself being sufficiently excellent, especially with the blessing that exposed Luo Sheng’s magical aura, this name Once again, its influence has been perfectly interpreted.
　　In two moments, the two new-faced companies became the biggest winners of the medical expo. Fame and fame, the fame has gone out, can the profit be far behind?
Sure enough, what followed was that the customer's order was already on the way. In the afternoon, 10 hospitals and distributors with medical device business licenses came to Bo Chuang Technology to place an order, and they directly placed 50,000 orders in one breath. Arm or leg prosthesis orders, this list of prosthetics 2.25 billion yuan.
However, what is interesting is that Chen Xin has a special additional agreement clause in the contract, that is, the partner can only earn up to 15% of the profit. If the profit exceeds the profit, the cooperation will be terminated. His original dream of creating a bionic prosthesis for Bochuang Technology Research is to give Amputees offer cheap products.
　......
　At present, although Bochuang Technology can obtain the medical device operation qualification and can supply the market, the production capacity cannot be improved, and its own sales channel network has not been established.
　　 This order has already subsidized the company's production capacity this year. Following this trend, this product will appear in short supply in the market.
　　 After all, it is 10 times lower in price than other prosthetic products on the market, and at the same time it is spiked in performance. One can imagine how tough this competitiveness is.
Due to insufficient supply, the price will inevitably be raised by the market, and the difference will be earned by the middleman. This obviously violates Chen Xin’s original intention. His short-term response strategy is also simple and rude. Whoever raises the price will not give him. Shipped.
　　 is so capricious because so far, Botron Technology's unparalleled competitiveness, only he can supply the market.
　　 However, Chen Xin also knows that it is impossible to fundamentally restrain the product from being squeezed high to make a large profit in the middle, because this is contrary to the basic logic of economic activity in which things are rare.
　　Middlemen always have a way to increase profits.
　　I really want the price to come down. Only raising the production capacity is the fundamental solution to the problem. In addition, I have to establish my own sales channel network. Chen Xin decided to learn from the marketing model of the offline direct stores on the Cote d’Azur.
　　 When the production capacity goes up, and its own sales channel is established, the price will naturally come down.
　　Huachang Technology is also gaining huge profits. On the same day, 42 major domestic and foreign pharmaceutical enterprise customers came to the door to place orders to purchase their "organ simulator" equipment, which can even be said to be scrambling.
　　 This device has great benefits and significance for biopharmaceutical research and development. Prior to this, no device has been able to simulate the entire circulatory metabolic process of the human body before the drug enters the clinical stage. It can only be tested with a white mouse.
　　Obviously, the mouse is not strict enough, and using volunteers will bring great risks.
But with this equipment, it is different to assist in the development of new drugs. The cost and cost of trial and error are greatly reduced, and the risk of clinical trials is greatly reduced. At the same time, the efficiency of research and development is improved. Because large-scale experiments can be carried out with confidence, the efficiency of new drug development is of course Will improve.
This set of equipment is not cheap, and the price of a single set is as high as 12.2 million US dollars. However, after learning of this medical device, domestic and foreign pharmaceutical companies still scramble for orders because the slow progress may delay the development of their own pharmaceutical companies. And because Huachang Technology was established soon, the production capacity is definitely not even for a while, then it will have to grab orders.
　　 is not cheap, but it is a trivial matter for these big pharmaceutical companies. International big pharmaceutical companies like Roche and Novartis have tens of billions of dollars in R&D investment each year.
　　Huachang Technology signed a total of 105 sets of purchase order contracts on the same day, with a total value of 1.28 billion US dollars, becoming the biggest winner of this medical expo, which is beyond everyone's expectations.
　　 Want to invest in VC...
Institutions are utterly stubborn now, and they have already begun to make huge profits, so don't think about financing.
The 42 pharmaceutical companies purchased this time are all well-known in the world. Dozens of international pharmaceutical companies including Roche, Novartis, Pfizer, Johnson & Johnson have become customers of Huachang Technology~EbookFREE.me~ is worth one It is mentioned that the dozens of pharmaceutical companies that have placed orders also see that the strength of domestic pharmaceutical companies is still far behind. In the list of customers on the purchase order, the top 30 global pharmaceutical companies are all listed, while domestic pharmaceutical companies do not One family is on this list.
　　 There is no doubt that the level of biopharmaceuticals is one of the important indicators to measure the comprehensive national strength of a country, and it is an important field related to national economy and people's livelihood, especially the outbreak of sudden public health events, which is of irreplaceable importance.
　　According to the latest ranking of global pharmaceutical companies published by the "Pharmaceutical Manager" magazine in North America this year, the top ten pharmaceutical companies in North America took 5 of them, 2 in Switzerland, 1 in France, and 1 in Japan.
　　 There are only four top-ranking pharmaceutical companies in the country that are also ranked first and 48th in the global pharmaceutical company ranking.
In the field of medical technology, there is obviously a long way to go, and this time Huachang Technology has shined, attracting all the top 30 global pharmaceutical companies, and struggling to place orders to purchase their medical equipment, it can be said that both It has made a lot of money for myself, and also made a face for this medical fair. It is undoubtedly a great encouragement to the development of the domestic medical industry.
Although the domestic pharmaceutical companies are not as good as the top 30 in the world, Huachang Technology has given priority to supplying several domestic pharmaceutical companies, and the number of equipment is one set of four. On the contrary, the large international pharmaceutical companies that are not bad are not only queuing in the back. And one family currently only supplies two sets.
　　 International pharmaceutical companies are very dissatisfied with this, but can only bear it. Who makes Huachang Technology the only equipment supplier in the world that can produce a complete set of human metabolic cycle simulation?
　　 What is the significance of this product for the development of clinical medicine, the pharmaceutical companies engaged in the field of biopharmaceuticals are the most clear.
　　……